Condition
Early Onset Neonatal Sepsis
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03932123UnknownPrimary
Antibiotic Therapy for Early Onset Neonatal Sepsis
NCT02886910Not ApplicableWithdrawn
Chorioamnionitis: Observation of at Risk Infants vs Standard Care
NCT02410486Completed
Early-Onset Sepsis an NICHD/CDC Surveillance Study
NCT02702297Completed
Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes
NCT00487019CompletedPrimary
Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment
Showing all 5 trials